{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:49:24Z","timestamp":1792597764512,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019266","name":"GlaxoSmithKline Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jaci.2024.10.024","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:03:06Z","timestamp":1730980986000},"page":"425-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-9108","authenticated-orcid":false,"given":"Kalliopi","family":"Domvri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsiouprou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina M.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana I.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Katsaounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Papamitsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Pastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Tryfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Fouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Papakosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Loukides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Porpodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.10.024_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1113100","article-title":"Airway remodeling heterogeneity in asthma and its relationship to disease outcomes","volume":"14","author":"Hsieh","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2024.10.024_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0183-2021","article-title":"Holy Grail: the journey towards disease modification in asthma","volume":"31","author":"Busse","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2024.10.024_bib4","article-title":"Targeting inflammation or remodeling in asthma? Is there a right way?","volume":"10","author":"Domvri","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.10.024_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.anai.2022.02.021","article-title":"Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions","volume":"129","author":"Oppenheimer","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaci.2023.06.005","article-title":"Eosinophils and tissue remodeling: relevance to airway disease","volume":"152","author":"Siddiqui","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/cea.13885","article-title":"Treating severe asthma: targeting the IL-5 pathway","volume":"51","author":"Principe","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.10.024_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","article-title":"Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma","volume":"17","author":"Minshall","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2024.10.024_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2004.09.034","article-title":"Increased TGF-beta2 in severe asthma with eosinophilia","volume":"115","author":"Balzar","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI17974","article-title":"Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics","volume":"112","author":"Flood-Page","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.10.024_bib11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/all.15627","article-title":"IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma","volume":"78","author":"Bajbouj","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.024_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/jpm12030333","article-title":"Asthma with fixed airflow obstruction: from fixed to personalized approach","volume":"12","author":"Bakakos","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib13","article-title":"Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration","volume":"10","author":"Bertels","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaci.2024.10.024_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.chest.2015.08.017","article-title":"Asthma-COPD overlap","volume":"149","author":"Barnes","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.10.024_bib15","doi-asserted-by":"crossref","first-page":"30s","DOI":"10.1183\/09031936.03.00404903","article-title":"Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes","volume":"39","author":"Buist","year":"2003","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2024.10.024_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib17","first-page":"545","article-title":"Associated markers for adult-onset\u00a0allergic asthma","volume":"14","author":"Bedolla-Barajas","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib18","first-page":"356","article-title":"ERS\/ATS statement on interventional pulmonology. European Respiratory Society\/American Thoracic Society","volume":"19","author":"Bolliger","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/all.15056","article-title":"From DREAM to REALITI-A and beyond: mepolizumab for the treatment of eosinophil-driven diseases","volume":"77","author":"Pavord","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.024_bib20","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib21","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.jaip.2023.07.024","article-title":"Mepolizumab in patients with severe asthma and comorbidities: 1-year REALITI-A analysis","volume":"11","author":"Liu","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.024_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.10.024_bib23","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1164\/ajrccm.162.4.9909044","article-title":"Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices","volume":"162","author":"Niimi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1183\/09031936.03.00085302","article-title":"Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma","volume":"22","author":"Gono","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thorax.57.3.242","article-title":"Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma","volume":"57","author":"Kasahara","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.10.024_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01507-2016","article-title":"Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling","volume":"49","author":"Berair","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12931-021-01767-z","article-title":"Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two phase III trials","volume":"22","author":"Lemiere","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2024.10.024_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.icb.7100044","article-title":"The regulatory role of TGF-beta in airway remodeling in asthma","volume":"85","author":"Makinde","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2024.10.024_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2008.05.020","article-title":"Airway hyperresponsiveness is dissociated from airway wall structural remodeling","volume":"122","author":"Siddiqui","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib31","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.3390\/ijms23084086","article-title":"Asthmatic eosinophils alter the gene expression of extracellular matrix proteins in airway smooth muscle cells and pulmonary fibroblasts","volume":"23","author":"Janulaityte","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2024.10.024_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/cells8040342","article-title":"Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies?","volume":"8","author":"Ito","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2024.10.024_bib33","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/cea.12156","article-title":"The relationship between eosinophilia and airway remodelling in mild asthma","volume":"43","author":"Wilson","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.10.024_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thoraxjnl-2014-205465","article-title":"Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia","volume":"70","author":"Hatchwell","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.10.024_bib36","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2024.10.024_bib38","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib40","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaci.2024.10.024_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.879","article-title":"Evaluating the effect of dupilumab on type 2 airway inflammation and mucus plugging in patients with uncontrolled moderate-to-severe asthma: the VESTIGE trial","volume":"153","author":"Castro","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.024_bib42","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00930-2019","article-title":"Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma","volume":"54","author":"Chachi","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105875","article-title":"Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline","volume":"162","author":"Marc-Malovrh","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2024.10.024_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2024.10.024_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.04.00077803","article-title":"Parameters associated with persistent airflow obstruction in chronic severe asthma","volume":"24","author":"Bumbacea","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.024_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaip.2021.09.023","article-title":"Anti-interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry","volume":"10","author":"Graff","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.024_bib47","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1183\/13993003.01129-2016","article-title":"Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study","volume":"48","author":"Wilson","year":"2016","journal-title":"Eur Respir J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924011680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924011680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:57:16Z","timestamp":1738742236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924011680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0091674924011680"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.10.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}